Gustaaf Albert Dekker Selected Research

Biomarkers (Surrogate Marker)

12/2022

Pravastatin suppresses inflammatory cytokines and endothelial activation in patients at risk of developing preeclampsia: INOVASIA study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gustaaf Albert Dekker Research Topics

Disease

3	Pre-Eclampsia (Preeclampsia) 12/2022 - 07/2014
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 12/2023
1	Birth Weight (Birth Weights) 12/2023
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2023
1	Abruptio Placentae (Placental Abruption) 07/2014
1	Rupture 07/2014
1	Eclampsia 07/2014
1	Spontaneous Abortion (Miscarriage) 01/2012
1	Gestational Diabetes (Gestational Diabetes Mellitus) 01/2012
1	Preterm Premature Rupture of the Membranes 01/2012
1	Hypertension (High Blood Pressure) 01/2012

Drug/Important Bio-Agent (IBA)

1	pristane (pristan)IBA 12/2023
1	Tyrosine (L-Tyrosine)FDA Link 12/2023
1	Pravastatin (Pravachol)FDA LinkGeneric 12/2022
1	Biomarkers (Surrogate Marker)IBA 12/2022
1	CytokinesIBA 12/2022
1	MagnesiumIBA 08/2020
1	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 08/2020
1	Clomiphene (Clomifene)FDA LinkGeneric 01/2012

Therapy/Procedure

1	Induced Labor 07/2014
1	Prenatal Care (Care, Prenatal) 07/2014
1	Therapeutics 07/2014